gsthr logo
Quick links to detailed datasheets for United States of America at gsthr.org

Smoking in United States of America

The overall smoking prevalence in the United States has been decreasing since 2006. 12.4% of the adult population are current smokers, down from 20.8% in 2006. This means there are now approximately 30.7 million people smoking in the country. 13.81% of men smoke whilst 10.77% of women are current smokers. The most recent data show there were 492,438 annual deaths attributable to tobacco smoking (approximately 221,600 women and 270,800 men). The annual percentage of all deaths attributable to tobacco smoking was 17.9% (women: 16.2%; and men: 19.3%). Nicotine vapes (e-cigarettes) are legal in the United States and there are 9.1 million vapers in the country, giving an adult vaping prevalence of 3.7% (women: 2.77%; and men: 4.55%). Vaping devices can only be sold to those 18 and older and can be purchased without a prescription. Health warnings are required on packaging and there are legal restrictions on their use in public places. Heated tobacco products are legal and can be marketed. Snus is also legal, but it can only be used by those aged 21 and older and a health warning on packaging is required. Nicotine replacement therapy (NRT) products can be marketed and are available to buy in many general shops without a prescription. The NRT market in the United States is worth €862.3 million. For further information and full references, click through to the detailed datasheets above.

Read articles from United States of America

October 03, 2024 by usc.edu

Evidence of Vaping’s Harmful Effects on Blood Vessels and the Left Ventricle of Heart

A study by researchers from USC, Keck School of Medicine, and UC Irvine reveals harmful effects of e-cigarettes and traditional cigarettes on cardiovascular health. Nicotine from both types damages blood vessels and heart function. The research used a fluid dynamics method to assess cardiovascular impact and calls attention to vaping's adverse effects. A smartphone tool for assessing risk in e-cigarette users is being developed. This innovative approach may revolutionize cardiovascular health monitoring. The study highlights the urgent need for awareness and informed choices regarding vaping and traditional smoking.

October 02, 2024 by clearingtheair.eu

It’s not illogical for vapers to follow populists. That should be a wakeup call for the centre left.

In 2019, Trump claimed he saved flavored vaping, but his policies led to a flood of disposable vapes. He also made it difficult to ship vapes and added to legal uncertainties for vapers. While some populists support safer nicotine products, the center-left has alienated vapers, accusing them of links to big tobacco. This stance has driven vapers towards right-wing parties. The left's reluctance to embrace harm reduction contrasts with the right's support for vapers' concerns, impacting political outcomes. The center-left's opposition to vaping overlooks its benefits for marginalized groups and undermines harm reduction efforts.

September 30, 2024 by spokesman.com

Washington advocates push for state ban on flavored vapes

A broad coalition of Washington educators, doctors, researchers and social justice advocates has launched a campaign to ban flavored nicotine vapes in the state, citing the product’s contribution to youth addiction. “We want to create a generation that will not be targeted by the tobacco industry, a generation who will not be susceptible to tobacco-related death and disease,” said Brittany Grant, regional advocacy director for Tobacco-Free Kids, one of the groups leading the coalition. “We can’t put profits over lives.”

September 25, 2024 by washingtonstatestandard.com

Washington advocates push for state ban on flavored vapes

A coalition in Washington is advocating to ban flavored nicotine vapes, aiming to reduce youth addiction. Led by Tobacco-Free Kids, the group plans to introduce legislation with the support of lawmakers in 2024. The campaign "Flavors Hook Kids Washington" seeks to prohibit all flavored tobacco products, including menthol cigarettes. Despite a decrease in youth vaping, concerns about increasing cigarette smoking arise from potential flavor bans. Advocates argue for protecting children from addiction and harmful marketing tactics, especially targeting vulnerable communities. Opponents mention the potential negative impact on smoking cessation efforts and advocate for considering all facts before implementing a ban.

September 25, 2024 by slate.com

What Trump Gets Right About a Key Harm Reduction Tool

Despite reluctance, acknowledgment was given to Trump for supporting flavored vaping. Trump's compromise in 2019 saved flavored vaping, benefitting smokers who switch to vape, despite critics questioning his motives. The decline in youth vaping can be attributed to various factors including awareness campaigns and policy changes. Democrats' push for flavor bans may inadvertently increase smoking rates and illicit markets. Attention to vaping issues is essential due to its impact on public health. The next president will face challenges in vaping policy, with potential influence on FDA decisions. Addressing tobacco harm reduction is crucial for both parties to consider, impacting millions of adult vapers and potentially preventing premature deaths.

September 24, 2024 by mjbizdaily.com

Marijuana advocates optimistic Florida will legalize adult-use sales

The slate of cannabis ballot referendums this November is headlined by Florida, the third-most-populous U.S. state, where voters will decide whether to legalize recreational marijuana through ballot measure Amendment 3. A victory in Florida would be one of the top legalization events in recent U.S. cannabis history, trailing only California’s successful referendum in 2016, New York’s Legislature approving adult use in 2021 and, most recently, President Joe Biden’s administration seeking to reschedule marijuana.

September 24, 2024 by csnews.com

FDA Continues Crackdown on Unauthorized E-Cigarettes

FDA issued warning letters to online retailers for selling unauthorized e-cigarette products favored by youth like Breeze and Mr. Fog. Companies had 15 days to respond and address violations, or face injunctions and penalties. Follow-up inspections showed some retailers failed to comply, resulting in a fine of $20,678 per retailer. FDA has conducted multiple inspections and filed complaints against manufacturers and retailers for selling unauthorized tobacco products. The recent penalties align with previous fines sought.

September 23, 2024 by youtube.com

CRUCIAL DECISION | Supreme Court to Review FDA Errors | RegWatch

The U.S. vaping industry faces a pivotal moment as the Supreme Court prepares to review a Fifth Circuit Court of Appeals decision. This ruling overturned FDA Marketing Denial Orders, including those affecting Triton Vapes LLC, seeking authorization to sell flavored nicotine vaping products.

September 20, 2024 by wsj.com

Tucker Carlson, Taking Aim at Zyn, Plans New Nicotine-Pouch Brand

Last year, Tucker Carlson criticized the nicotine-pouch brand Zyn and was frustrated by the response from its manufacturer. As a result, he plans to launch his own competing nicotine-pouch brand, Alp, in November. Carlson claimed that Zyn caters to women and liberals, citing donations by Philip Morris International (Zyn's owner) employees to Democratic candidate Kamala Harris as proof the company is disconnected from its conservative user base.

September 20, 2024 by thehill.com

Tucker Carlson plans to launch line of nicotine pouches

Conservative pundit Tucker Carlson says he plans to launch a line of nicotine pouches. The former Fox News host-turned-internet personality told The Wall Street Journal this week he plans to launch a brand called Alp to compete with the popular Zyn pouches manufactured by Philip Morris. The Journal reported that Carlson’s longtime business associate and partner on the nicotine venture Neil Patel said the two plan to comply with federal regulations for the venture, but he declined to say if they would seek approval from the Food and Drug Administration.